Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.38 +0.26 (+23.87%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) Receivables (2026)

Updated

Nautilus Biotechnology (NAUT) recorded Receivables of $100,000 in Q2 2026.

Analysis

Nautilus Biotechnology (NAUT) Receivables (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 11.14 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 8.60 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 3.97 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 1.67 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 6.36 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 3.74 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 3.05 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 2.36 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 955.70 Mn
10 Nautilus Biotechnology 141.22 Mn 141.22 Mn 175,000.00 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
API Access

Nautilus Biotechnology Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NAUT&period=max&api_key=YOUR_API_KEY